Status:
COMPLETED
Prevalence and Impact of COVID-19 on Maternal and Infant Health in African Populations
Lead Sponsor:
Barcelona Institute for Global Health
Collaborating Sponsors:
Centre de Recherche Médicale de Lambaréné
Centro de Investigação em Saúde de Manhiça
Conditions:
SARS-CoV2 Infection
COVID-19
Eligibility:
FEMALE
Brief Summary
There is growing evidence that COVID-19 threatens maternal and perinatal health. Pregnant women are at higher risk of severe complications (severe pneumonia, hospitalizations, intensive care unit admi...
Eligibility Criteria
Inclusion
- Permanent resident in the study area
- Agreement to deliver in the study site's maternity(ies) wards
Exclusion
- Planning to move out the study area in the following 7 months from enrolment
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05303168
Start Date
July 1 2021
End Date
May 31 2024
Last Update
September 20 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherches Médicales de Lambaréné (CERMEL)
Lambaréné, Gabon
2
Centro de Investigação em Saúde de Manhiça (CISM)
Manhiça, Mozambique